Portal Cavernoma in the Era of Mesoportal Shunt (Rex) and Liver Transplant in Children

Abstract

Objective The mesoportal shunt (MPS) and liver transplantation (LT) have changed the scenario of extrahepatic portal vein obstruction (EHPVO) since the MPS, the only “curative” technique, can now be offered in asymptomatic patients and also thrombotic complications of LT have increased the incidence of EHPVO.

Material and Methods A retrospective study of patients undergoing surgery for EHPVO was conducted between 1990 and 2015. An analysis was done for the shunt permeability and clinical evolution over time.

Results Of the 73 children with EHPVO, 39 were operated (12 posttransplant and 27 idiopathic). The median age at surgery was 9.36 years (range, 1.60–17.42 years). The MPS was the technique of choice; it was offered in 21 patients but eventually could be performed in only 18 (9 posttransplant and 9 idiopathic). The results of MPS were better in idiopathic (just one thrombosis successfully converted into mesocaval bypass). In the MPS after LT (n = 9), six shunts are permeable, two became thrombotic (one patient requiring retransplantation), and one late thrombosis occurred and the patient died eventually because of gastrointestinal bleeding. In the remaining patients (21 out of the 39), MPS was not performed because of intrahepatic cavernoma, portal vein hypoplasia, or insufficient length of vascular graft (especially in left lateral segment graft LT, since the portal vein is usually located in the right upper quadrant). They underwent 10 distal splenorenal shunts (DSRS) (1 posttransplant and 9 idiopathic), 5 proximal splenorenal shunts (PSRS) (1/4), 6 mesocaval shunts (1/5), and 1 modified Sugiura procedure. The results with DSRS have been favorable (one thrombosis, converted into mesocaval bypass). In the PSRS no thrombosis was identified and in the mesocaval shunt one early thrombosis occurred. Posttransplantation group had higher risk of shunt thrombosis, regardless of the surgical technique (chi-square, 0.021). The total increase of platelets after 6 months was not different in MPS as compared with other surgical techniques (analysis of variance, 0.110).

Conclusions The MPS is the technique of choice in EHPVO for idiopathic thrombosis as well as secondary to LT. Not all cases are favorable for MPS, so the surgeon must consider the possibility of alternative techniques for EHPVO. The results in terms of shunt patency are much better in idiopathic cavernoma that posttransplant patients.

Keywords

mesoportal shunt - thrombosis - portosystemic shunts

• References

• 1 Weiss B, Shteyer E, Vivante A , et al. Etiology and long-term outcome of extrahepatic portal vein obstruction in children. World J Gastroenterol 2010; 16 (39) 4968-4972
• 2 Lautz TB, Keys LA, Melvin JC, Ito J, Superina RA. Advantages of the meso-Rex bypass compared with portosystemic shunts in the management of extrahepatic portal vein obstruction in children. J Am Coll Surg 2013; 216 (1) 83-89
• 3 Orloff MJ, Orloff MS, Girard B, Orloff SL. Bleeding esophagogastric varices from extrahepatic portal hypertension: 40 years' experience with portal-systemic shunt. J Am Coll Surg 2002; 194 (6) 717-728 , discussion 728–730
• 4 de Ville de Goyet J, Clapuyt P, Otte JB. Extrahilar mesenterico-left portal shunt to relieve extrahepatic portal hypertension after partial liver transplant. Transplantation 1992; 53 (1) 231-232
• 5 Shneider B, Emre S, Groszmann R , et al. Expert pediatric opinion on the Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. Pediatr Transplant 2006; 10 (8) 893-907
• 6 Shneider BL, Bosch J, de Franchis R , et al; expert panel of the Children's Hospital of Pittsburgh of UPMC. Portal hypertension in children: expert pediatric opinion on the report of the Baveno v Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension. Pediatr Transplant 2012; 16 (5) 426-437
• 7 Superina R, Shneider B, Emre S, Sarin S, de Ville de Goyet J. Surgical guidelines for the management of extra-hepatic portal vein obstruction. Pediatr Transplant 2006; 10 (8) 908-913
• 8 Sugiura M, Futagawa S, Hidai K. A new technique for the treatment of esophageal varices. Bull Soc Int Chir 1975; 34 (3) 175-177
• 9 Superina RA, Weber JL, Shandling B. A modified Sugiura operation for bleeding varices in children. J Pediatr Surg 1983; 18 (6) 794-799
• 10 Chaves IJ, Rigsby CK, Schoeneman SE, Kim ST, Superina RA, Ben-Ami T. Pre- and postoperative imaging and interventions for the meso-Rex bypass in children and young adults. Pediatr Radiol 2012; 42 (2) 220-232 , quiz 271–272
• 11 Kwan SW, Fidelman N, Durack JC, Roberts JP, Kerlan Jr RK. Rex shunt preoperative imaging: diagnostic capability of imaging modalities. PLoS ONE 2011; 6 (7) e22222
• 12 de Ville de Goyet J, Gibbs P, Clapuyt P, Reding R, Sokal EM, Otte JB. Original extrahilar approach for hepatic portal revascularization and relief of extrahepatic portal hypertension related to later portal vein thrombosis after pediatric liver transplantation. Long term results. Transplantation 1996; 62 (1) 71-75
• 13 Gibelli NEM, Tannuri ACA, Tannuri U , et al. Rex shunt for acute portal vein thrombosis after pediatric liver transplantation in children with biliary atresia. Transplant Proc 2011; 43 (1) 194-195
• 14 Vannevel G, Clapuyt P, Reding R, Menten R. Spontaneous meso-portal shunt following orthotopic liver transplantation in a child. Pediatr Radiol 2010; 40 (Suppl. 01) S92-S94
• 15 de Ville de Goyet J, Lo Zupone C, Grimaldi C , et al. Meso-Rex bypass as an alternative technique for portal vein reconstruction at or after liver transplantation in children: review and perspectives. Pediatr Transplant 2013; 17 (1) 19-26